Dec. 12 at 3:21 PM
$CRDF longs, particularly the regulars in our little community on this page, know that the volume right now is well outside the normal range for this stock, not just in recent months but across years of experience with it.
There appears to be a very significant interest now in this ticker from smaller investors, and given the fact that we smaller longs already hold the majority of the company's shares, I see a price stability on the horizon that we never enjoyed when the bulk of shares were institutionally owned.
We are poised for nosebleed inducing gains in the coming weeks, if this volume continues. And even if the larger holdings take profits (some probably triggered automatically or by company rules,) those sold shares will fall into tight fists less likely to part with them when the data points towards an FDA approval.
